```html

X‑ray–Induced Skin Injury

Overview

X‑ray–induced skin injury (also called radiation‑induced skin injury or radiation dermatitis from diagnostic/therapeutic X‑ray exposure) is damage to the skin that occurs after exposure to ionizing radiation from X‑ray equipment. The injury can range from mild erythema (redness) to severe ulceration and necrosis.

• Who it affects: Anyone who undergoes high‑dose or repeated X‑ray procedures—such as interventional radiology, fluoroscopy‑guided cardiac catheterizations, computed tomography (CT) scans with dose‑modulation, and radiation oncology treatments—can develop skin injury.
• Prevalence: In the United States, about 2‑3 % of patients who receive >5 Gy (gray) skin dose during interventional procedures develop clinically significant dermatitis. Among radiation‑oncology patients, acute skin reactions occur in up to 90 % of those receiving >2 Gy per fraction, though most are mild and self‑limited.

The condition is generally dose‑dependent, but individual susceptibility varies with age, skin type, comorbidities, and genetic factors.

Symptoms

Skin injury from X‑ray radiation may appear within hours to weeks after exposure. The spectrum of findings is summarized below:

Acute (< 24 h – 2 weeks)

• Erythema: Redness resembling a sunburn; often the first sign.
• Warmth & swelling: The affected area may feel hot and be mildly edematous.
• Pruritus or pain: Itching or tenderness that can be mild to moderate.
• Dry desquamation: Fine, flaky skin that peels off without oozing.

Sub‑acute (2–6 weeks)

• Moist desquamation: Weeping, blister‑like patches that may ooze serous fluid.
• Edema: More pronounced swelling, especially in dependent areas.
• Hyperpigmentation: Darkening of the skin that may persist after healing.

Chronic (> 6 weeks)

• Fibrosis: Hard, leathery skin due to collagen deposition.
• Telangiectasia: Visible small blood vessels.
• Atrophy or ulceration: Thinning skin that can break down into non‑healing ulcers.
• Chronic pain or neuropathic sensations: Burning or tingling that may persist.

Causes and Risk Factors

The primary cause is ionizing radiation depositing energy in the epidermis and dermis, producing free radicals that damage cellular DNA, blood vessels, and extracellular matrix.

Procedural sources

• Fluoroscopy‑guided cardiac catheterization (average skin dose 1‑8 Gy).
• Endovascular aneurysm repair and peripheral vascular interventions.
• Complex CT‑guided biopsies or interventional oncology procedures.
• Radiation therapy for cancer (external beam, brachytherapy).

Patient‑related risk factors

• High cumulative dose: ≥2 Gy in a single exposure, or ≥5 Gy over multiple sessions.
• Skin type: Fair skin (Fitzpatrick I‑II) is more radiosensitive.
• Age: Children and elderly have reduced repair capacity.
• Comorbidities: Diabetes, peripheral vascular disease, connective‑tissue disorders, and immunosuppression increase risk.
• Medications: Chemotherapy agents (e.g., 5‑fluorouracil, doxorubicin), retinoids, and certain antibiotics (e.g., tetracyclines) can potentiate radiation damage.
• Repeated exposure: Multiple procedures within a short time frame raise cumulative dose.

Diagnosis

Diagnosis is clinical but should be supported by a thorough history, physical exam, and, when needed, adjunctive testing.

Step‑by‑step approach

1. History: Document type of X‑ray procedure, date(s), estimated dose (if known), and any prior radiation exposures.
2. Physical examination: Assess location, size, depth, and character of skin changes; note any ulceration or infection.
3. Dosimetry review: Obtain procedural radiation dose reports from the radiology or cardiology department. Skin‑dose maps can pinpoint high‑dose zones.
4. Imaging (if needed): High‑resolution ultrasound or MRI can evaluate underlying tissue involvement in severe cases.
5. Biopsy: Reserved for atypical lesions or when malignancy cannot be excluded; shows epidermal necrosis, dermal fibrosis, and vascular changes.

Classification systems

• RTOG/EORTC Acute Radiation Morbidity Scoring: Grades 1–4 based on erythema, desquamation, and ulceration.
• CTCAE (Common Terminology Criteria for Adverse Events): Widely used in clinical trials.

Treatment Options

Management aims to alleviate symptoms, promote healing, and prevent infection or progression to necrosis. Treatment is tailored to severity (grade) and patient factors.

General measures (all grades)

• Gentle cleansing with mild soap; avoid scrubbing.
• Keep the area moisturized with emollients (e.g., petrolatum, hypoallergenic creams).
• Protect from further radiation or mechanical trauma.
• Educate patients on signs of infection.

Grade 1‑2 (mild erythema to dry desquamation)

• Topical steroids: Low‑ to medium‑strength (hydrocortisone 1 % or triamcinolone 0.1 %) applied 2‑3 times daily for 1‑2 weeks.
• Topical barrier creams: Zinc oxide or silicone‑based preparations to reduce friction.
• Cold compresses: 10‑15 minutes, several times a day, to reduce heat and discomfort.

Grade 3 (moist desquamation, painful ulceration)

• Advanced dressings: Hydrocolloid, alginate, or foam dressings that maintain a moist environment.
• Topical antibiotics: Mupirocin 2 % or bacitracin to prevent secondary infection.
• Systemic analgesia: NSAIDs or acetaminophen; consider short courses of oral opioids for severe pain.
• Debridement: Gentle mechanical or enzymatic debridement by a wound‑care specialist.

Grade 4 (full‑thickness necrosis, non‑healing ulcer)

• Surgical intervention: Serial debridement, skin grafting, or flap reconstruction.
• Hyperbaric oxygen therapy (HBOT): 2.0‑2.5 ATA for 90‑120 minutes, 5‑6 sessions/week; improves neovascularization (supported by NIH evidence).
• Systemic antibiotics: If infection is documented, culture‑guided therapy.
• Pain management: Multimodal approach, possibly including neuropathic agents (gabapentin, duloxetine).

Lifestyle & adjunctive strategies

• Quit smoking – improves microcirculation.
• Optimize nutrition: protein ≥ 1.2 g/kg/day, vitamin C, zinc.
• Control blood glucose in diabetics – reduces wound‑healing delays.

Living with X‑ray–Induced Skin Injury

Long‑term care focuses on skin protection, monitoring, and maintaining quality of life.

Daily skin‑care routine

1. Wash gently with lukewarm water; pat dry.
2. Apply a fragrance‑free moisturizer immediately after drying.
3. Use a silicone‑based scar gel once the wound has epithelialized to minimize hypertrophic scarring.

Clothing & equipment

• Wear soft, cotton clothing that does not rub the affected area.
• Avoid tight belts, straps, or orthotic devices over the injury.
• If the injury is on a limb, consider protective padding during activities.

Follow‑up schedule

• First review 1‑2 weeks after the initial presentation.
• Subsequent visits every 4‑6 weeks until complete healing.
• Annual skin checks for chronic changes (telangiectasia, fibrosis).

Psychosocial aspects

Visible skin changes can affect self‑esteem. Encourage patients to seek support groups, counseling, or referral to a psychologist if distress becomes significant.

Prevention

Because radiation injury is dose‑related, most prevention strategies focus on minimizing exposure and protecting vulnerable skin.

For health‑care providers

• Low‑dose protocols: Use the “as low as reasonably achievable” (ALARA) principle; adjust fluoroscopy frame rates, collimation, and pulse‑width.
• Skin‑dose monitoring: Real‑time dosimeters, cumulative dose charts, and automated alerts for >2 Gy skin dose.
• Protective shields: Lead‑equipped aprons, thyroid collars, and specifically designed skin‑sparing pads for high‑dose fields.
• Staged procedures: When possible, split large dose procedures into separate sessions to allow tissue recovery.

For patients

• Inform providers of any prior radiation exposure.
• Ask about alternative imaging (ultrasound, MRI) when appropriate.
• Maintain good hydration and nutrition before and after procedures.
• Report any skin changes within 24 hours of an X‑ray‑intensive study.

Complications

If untreated or inadequately managed, radiation‑induced skin injury can lead to:

• Secondary bacterial, fungal, or viral infections (e.g., cellulitis, MRSA).
• Chronic ulceration with risk of osteomyelitis when overlying bone.
• Fibrotic contractures limiting joint motion.
• Radiation‑induced malignancies (rare, but documented with very high cumulative doses).
• Psychological distress and reduced quality of life.

When to Seek Emergency Care

Seek immediate medical attention if you notice any of the following:

• Sudden, severe pain unrelieved by over‑the‑counter medication.
• Rapidly expanding ulceration or necrotic tissue.
• Signs of infection: fever >38°C (100.4°F), increasing redness, swelling, pus, or foul odor.
• Bleeding that does not stop with simple pressure.
• Loss of sensation or motor function in the affected area.

Call 911 or go to the nearest emergency department if any of these symptoms develop.

References

• Mayo Clinic. “Radiation dermatitis.” mayoclinic.org (2023).
• CDC. “Radiation Emergencies.” cdc.gov (2022).
• National Cancer Institute. “Radiation Therapy Side Effects.” cancer.gov (2024).
• World Health Organization. “Ionizing radiation, health effects and protective measures.” WHO Fact Sheet (2023).
• Cleveland Clinic. “Management of Radiation Skin Injury.” clevelandclinic.org (2023).
• American Society of Interventional Radiology. “Radiation Dose Management Guidelines.” ASIR (2022).
• Jansen, J. et al. “Hyperbaric oxygen for radiation‑induced tissue injury: a systematic review.” *Radiology*, 2021.

```